Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04997902
Title Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Kura Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center RECRUITING Duarte California 91010 United States Details
Lake Nona DDU (Florida Cancer Specialists) RECRUITING Orlando Florida 32827 United States Details
University of Maryland School of Medicine (Marlene and Stewart Greenebaum Comprehensive Cancer Center) RECRUITING Baltimore Maryland 21201 United States Details
Johns Hopkins University School of Medicine (Sidney Kimmel Comprehensive Cancer Center) RECRUITING Baltimore Maryland 21231 United States Details
Dana-Farber Cancer Institute (Head and Neck Cancer Treatment Center) RECRUITING Boston Massachusetts 02215 United States Details
Washington University, School of Medicine RECRUITING Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
UPMC Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
UT Southwestern Medical Center (Harold C. Simmons Comprehensive Cancer Center) RECRUITING Dallas Texas 75390 United States Details
University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
University of Wisconsin Carbone Cancer Center RECRUITING Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field